Martin P. Bogsrud

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons et al. · The Lancet · 2021 · 305 citations · Full text

Public Health, Endocrinology, Genetics +13

Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia

Katherine Wilemon, Jasmine Patel, Carlos A. Aguilar‐Salinas et al. · JAMA Cardiology · 2020 · 258 citations · Full text

Medicine, Cardiology, Preventive Medicine +15

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Martina De Marco, Christophe Stevens et al. · Atherosclerosis · 2018 · 238 citations · Full text

Medicine, Cardiology, Genetics +11

Familial hypercholesterolaemia: A global call to arms

Antonio J. Vallejo‐Vaz, Sreenivasa Rao Kondapally Seshasai, Della Cole et al. · Atherosclerosis · 2015 · 179 citations · Full text

Life Sciences, Cardiology, Genetics +9

Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy

Matthias Hermann, Martin P. Bogsrud, Espen Molden et al. · Clinical Pharmacology & Therapeutics · 2006 · 137 citations

Pharmacy, Pharmacokinetics, Pharmacology +11